In Light of Two Major Failed Trials, FORUM Pharma Closes Its Doors This Week
Infinity Pharma (INFI) Cuts Jobs by 58% as AbbVie (ABBV) Terminates Duvelisib Collaboration Deal
Mayne Pharma Expands into U.S. Through the $652 Million Acquisition of 42 Generic Drugs From Allergan (AGN) and Teva (TEVA)
Speedy Review for Genentech (RHHBY)’s OCREVUS, Action Date December 28
Dow Chemical  (DOW) to Cut 2,500 Jobs Globally
Biotech Startup Immage Biotherapeutics (IMMG) Gets Ready for Philadelphia Expansion
Novartis AG (NVS) Taps Xencor's Bispecifics Expertise in $150 Million Immuno-Oncology Deal
Marinus Pharma (MRNS)'s Primary Endpoint Not Met in Ganaxolone Phase II
Celyad’s CHART-1 Phase III Shows No Significant Difference on Primary Endpoint
Regulus (RGLS) Shares Crumble As FDA Puts Hep C Treatment on Hold
AstraZeneca PLC (AZN) Gets EU Approval For Zavicefta Antibiotic Treatment
Pfizer (PFE) Expands and Invests $350 Million in China Biotech Hub, First in Asia
How Amgen (AMGN) Fits Into Pfizer (PFE)’s Restructuring Plans
Sanofi (SNY) Inks Deal to Swap Business with Boehringer Ingelheim
NewLink Genetics (NLNK) Stock Slides and Company Lays Off 87 After Failed Trial
British Trade Group Suspends Astellas (ALPMY) After Drugmaker Disguised the True Purpose of a Meeting Held for Doctors
How Brexit Is Affecting UK’s Drug Companies, Including GlaxoSmithKline (GSK), Gilead (GILD) and AstraZeneca PLC (AZN)
Bristol-Myers Squibb (BMY)'s Miracle Drug Opdivo Receives Yet Another Breakthrough Designation
See All News >
//-->